Clonal development of neoplasms and hierarchal stem cell relationships can be studied conveniently in people who have two genetically distinct types of cells. Especially useful for this purpose is the cellular mosaicism in women heterozygous for the X-chromosome-linked glucose-6-phosphate dehydrogenase (G6PD) . Because the G6PD locus undergoes X-chromosome inactivation, only one of the two G6PD genes is active in each somatic cell. Therefore, women heterozygous for the usual B gene (GdB) and a variant such as GdAhave two cell populations -one synthesizing B-type G6PD and the other, A-type enzyme. Tumours with a singlecell (clonal) development exhibit only one type of G6PD, but those arising from many cells may show both B and A enzymes. Only one type of G6PD was detected in granulocytes, red cells and platelets from 30 females heterozygous for G6PD who had chronic myelocytic leukaemia (CML) , indicating that this disorder involves multipotent marrow stem cells and that it develops clonally. Detailed studies with G6PD indicate that B-lymphoid and perhaps T-lymphoid cells arise from the stem cell involved by the leukaemia. Acute myeloid leukaemia is heterogeneous with respect to the pattern of stem cell involvement and the nature of remission. In some patients, the disease involves stem cells with multipotent differentiative expression, whereas in others it involves progenitors with differentiative expression restricted to the granulocytic pathway. G6PD and chromosome studies also suggest that We have investigated the possibility of stem cell renewal and differentiation in human malignant epithelium. This has been performed both at the theoretical level and practically by assessing cellular features of human ovarian carcinomas. Cells derived from this type of tumour are heterogeneous with respect to a number of functional and phenotypic markers (labelling index, clonogenicity in tissue culture, histochemically-marked differentiation, cell surface expression of ovarian tumourassociated antigens). The fact that physical properties of the cells also change with differentiation has allowed the fractionation of tumour cell populations (on the basis of density and/or volume) and the putative ordering of differentiation markers. We Bladder cancer is a disease of multifocal primaries with a 70% recurrence rate within 5 years. Eighty per cent of first patients present with benign, welldifferentiated papillary lesions but it can also occur as flat, poorly-differentiated invasive carcinoma arising from diffuse carcinoma in situ . Previously, using experimental rat models, we demonstrated the development of the papillary lesions to be stepwise through a multistage process analogous to initiation and promotion in the skin. By contrast, the response of the B6D2F1 mouse to the bladder carcinogen BBN was less uniform and indicated that not all invasive bladder lessions necessarily progress via the same mechanism. The response of the experimental bladder cancer models to treatment with retinoids (analogues of vitamin A) has now been studied. In the rat model, certain retinoids delay the latent period before tumour growth commences, thus reducing the time-related prevalence of bladder cancer and increasing the survival of the animals. This was predictable for tumours which develop via initiation and promotion, for retinoids are known to inhibit stage 2 promotion (clonal expansion of preneoplastic cells) in vitro. In the mouse model also retinoids delay the development of the majority of invasive carcinomas, but a small minority of rapidly developing, aggresively invasive cancers appear to be unaffected by this treatment. The development of such lesions may or may not be stepwise, but it does not appear to involve "promotion" in the same way as does the development of papillary carcinomas. These To determine whether this concept applies to the oesophagus, the ability of relevant nitrosamines to deplete oesophageal and liver AAP was studied. Extracts of these organs from treated animals were tested for their ability to remove 06AG on incubation with previously alkylated DNA. Methylbenzylnitrosamine (oesophageal specific), diethylnitrosamine (carcinogenic for oesophagus and liver), and dimethylnitrosamine (carcinogenic for liver but not for oesophagus) depleted liver and oesophageal AAP, and dose response studies revealed a selective action on the target organs. Methylphenylnitrosamine (MPN, oesophageal specific) did not deplete but induced AAP in liver and possibly in oesophagus. This result supports the evidence that MPN does not alkylate DNA. The higher levels of AAP found in human organs may not protect man against the majority of environmental nitrosamines. The promotion of N-nitroso compound formation at neutral pH by bacteria infecting certain bodily sites (stomach, urinary bladder) may account for the increased incidence of carcinogenesis observed in certain population groups. N-nitrosamines are formed in aqueous systems by an acid catalysed reaction between nitrite and secondary amine (pH optimum 2-3), the reaction rate decreasing rapidly as the pH approaches neutrality. Much early work was prone to artefacts caused by inadequate controls and lack of specific detection methods. In this work bacterial cells were added to a reaction mixture of secondary amine and nitrite in phosphate buffer at neutral pH. Any nitrosamine was extracted and analysed by GC-TEA (Thermal Energy Analyser-specific for nitrosamines The object of this study was to develop a noninvasive method for studying HPV infection in the uterine cervix and to study the link between HPV infection and cervical oncogenesis. Cervical scrapings were obtained from 5 groups of women: (i) well women, (ii) women with CIN, (iii) women successfully treated for CIN, (iv) VD clinic women free from genital warts, and (v) VD clinic women with genital warts.
DNA purified from these samples was blotted onto nylon filters and hybridised sequentially to HPV type 6 DNA and to a repetitive sequence associated with the globin gene, both cloned into the pBR 322 plasmid and labelled with 32P by nick translation (Rigby et al., 1975) .
Results are summarised below. The percent positive for HPV 6 DNA is calculated as a proportion of the cases positive for the repeat probe. Clearly a non random pattern of chromosome losses and gains exists in these cell lines similar to that observed in direct preparations from tumour material (Atkin & Baker (1983) Cancer Genet. Cytogenet., 10, 199) . Loss of specific wild type genes by gross chromosome change mat be important in the aetiology of testicular tumours, as it appears to be in retinoblastoma (Cavenee et al. (1984) Although the cells from disseminating malignant tumours rapidly arrive in all organs, they only grow in some sites, and success or failure in forming metastatic deposits is dependent upon interaction between properties of the tumour cells and the microenvironment. In the present study the influence of microenvironmental conditions of specific organs upon tumour cell survival and behaviour was investigated in tissue culture using spontaneous mouse mammary carcinomas. In cocultures, some organs (lung, ovary) encourage the survival and the attachment of the tumour cells, while others (liver, thyroid) accelerate the process of cell destruction. These effects are exerted by soluble mediators which can be transferred with cell-free organ-conditioned medium from one culture to another and are significantly more pronounced in cells from the same animal species. The "stimulatory" influence is rather a preservation of the tumour cells, than a stimulation of their multiplication, as suggested by 125IUdR-uptake studies. It is known that, after in vivo inoculation, these mammary tumours develop metastases mainly in the lungs, and occasionally in the kidneys or ovaries, and the "encouraging" influences of these same organs in vitro are thus in good agreement with the in vivo observations. The findings also endorse the hypothesis that certain normal organs can suppress the formation of metastases even though cells from the same tumour have formed them elsewhere.
Effects of the concentrations of oxygen in the ambient atmosphere on growth in vitro of rodent cancer cells R. Clarke, P.V. Senior, K. Moore & P. Alexander CRC Dept. of Medical Oncology, University of Southampton, Southampton General Hospital, UK. The concentration of oxygen encountered by cancer cells arrested in capillary beds is much higher than that in the extracellular fluid which is the normal milieu in which they grow in vivo. This raises the possibility that oxygen toxicity contributes to the high rate of intravascular destruction of cancer cells that have been shed into the circulation. We have compared the growth in vitro of cancer cells taken directly from a number of rodent tumours in atmospheres containing 5% and 20% oxygen. Growth was assessed by measurement of increase in cell numbers in microwells (the proliferation assay) and by the fraction of cells forming colonies in soft agar (the clonogenic assay). With most of the tumours studied growth in both assays was greater in 5% than in 20% oxygen. This oxygen effect was not observed with two carcinomas tested, but these cells could be rendered sensitive to the toxic effects of 20% oxygen by depletion of cellular glutathione by treatment with the glutathione synthesis inhibitor, buthionine sulphoximine.
The reverse phenomenon (i.e. induction of resistance to 20% oxygen) was seen when oxygen sensitive tumour cells had been established in cell culture for a number of passages. So far we have conflicting data on the permanence of this change following re-establishment of the cultured cells as a tumour in vivo and cannot decide whether it is an adaptive response of the cells or whether oxygen resistant variants, which have no proliferative advantage in vivo were selected in vitro. Human autopsy data shows that for carcinoma cells that have gained access to the arterial circulation the adrenal is a frequent site for metastasis in spite of the small proportion of cardiac output received by this organ. In experimental animals the same has been observed following direct inoculation of a variety of cancer cells into the left ventricle. We have studied the metastatic pattern of 3 syngeneic rat rumours (sarcoma, carcinoma and hepatoma) injected into the left ventricle via carotid cannulae. The fate of inoculated cells was determined with 125IUdR-labelled cells and the cardiac output distribution by injecting radioactive microspheres.
The adrenal was the commonest site for metastasis for all 3 tumours (80 of 86 rats) despite receiving only 0.4% of cardiac output (n= 12) and trapping only 0.2% of tumour cells (n= 11). In contrast the kidney developed metastasis rarely (1 of 86 rats) despite receiving 13.4% of cardiac output and trapping 9.3% of cells. Injection of a cell dose such that a predicted 100 sarcoma cells arrested in the adrenals produced metastasis in 10 out of 10 rats and a predicted 10-30 cells produced metastases in 5 of 7 rats whereas more than 45,000 cells arrested in the kidney failed to produce metastasis in 18 rats.
Metastatic pattern did not correlate with vascularity/gram and autoradiography demonstrated that the tumour cells were trapped at the arterial end of the capillaries in both kidney and adrenal. Pharmacological manipulations of adrenal function altered the metastatic pattern.
We conclude that local biochemical factors may be responsible for preferential growth in adrenals. In considering monoclonal antibodies for targeting antitumour agents the heterogeneity of antigen expression between cells in an individual tumour is of importance. This heterogeneity was examined in colorectal cancers and related to DNA content abnormalities. Sixteen colorectal cancers were disaggregated to yield viable tumour cell suspensions. These were tested by indirect immunofluorescence with a panel of antitumour monoclonal antibodies -anticolonic adenoma (C14), antiCEA/NCA (C24) and antiCEA (LI 1/285) and normal mouse immunoglobulin (NMI). The flow cytometric measurement of fluorescence was analysed and cells subdivided arbitrarily into those binding antibody at different degrees. The percentage of the total cells falling into each "band" was calculated (see Table I ). Table II ). Circulating leukocyte populations were investigated using monoclonal antibodies and flow cytometry (FACS 420) in tumour bearing patients (TBP) with concurrent functional assays (mixed leukocyte culture, MLC). To assess plasma and CSF MTX levels we studied 4 patients (3 females, 1 male) undergoing combination chemotherapy for high grade NHL. As part of this regime on Day 10 they received i.v. bolus MTX (300mgm-2) followed by a 12h infusion of MTX (1.2gm-2). Prior to commencement of chemotherapy a lumbar indwelling fine bore CSF catheter was inserted. Paired blood and CSF samples were obtained continuously for 24 h. (Time 0.5, 15, 30, 45, 60, 90min 2, 3, 4, 5, 6, 8, 12, 15 and 24 courses were selected to receive CTX 180mgkg-1, VP16 lgm-2 and mesna 325mgkg-' as LDIT 4 weeks after completion of induction therapy. Marrow harvested from the patient prior to LDIT was re-infused 36h later. Prophylactic radiotherapy 4000 cGy was given to the primary site in 10 of the 22 patients 6 weeks after LDIT (see Table below ).
Major toxicities were; emesis and myelosuppression 100%, diarrhoea 50%, mucositis 36%, skin rash 23% and haematuria 9%. The survival of patients receiving LDIT was not better than the survival of comparable groups from the 55 patients who received 3 course of induction treatment alone. This pilot study has failed to show any benefit from LDIT in the management of SCLC. Using a novel immunisation regime, we have generated a number of murine monoclonal antibodies against human pancreatic exocrine cancer (GER) which appear to have sufficient selectivity for pancreatic cancer cells to be of diagnostic and other potential use. Supernatants from these hybridomas were screened on formalinfixed paraffin-embedded tissue sections. The initial screen was carried out on normal non-neoplastic human pancreas and the original GER pancreatic tumour. Five supernantants stained malignant epithelium in pseudoductules as well as normal pancreatic duct epithelium. DD9E7 produced the most intense staining of malignant epithelium and was further tested against other pancreatic adenocarcinomas and a wide variety of nonneoplastic and malignant tissues in both fixed and frozen tissue sections. The preparation and properties of a methotrexatehuman serum albumin-antibody conjugate which retains both antibody binding activity and complete drug cytotoxicity has been previously reported (Garnett et al. (1983) Int. J. Cancer, 31, 661). It has been proposed that drug conjugates would be taken up into cells and the drug released by lysosomal enzymes (De Duve et al. (1974) . Biochem. Pharmacol., 23, 2495). To test this hypothesis for our conjugate we have assessed the ability of the various inhibitors of lysosomal enzymes to affect the cytotoxicity of both conjugated and free methotrexate to target cells expressing the relevant antigen in a "24h treatment" assay.
Ammonium chloride, which reduces lysosomal enzyme activity by raising lysosomal pH, reduced the cytotoxicity of both free and conjugated methotrexate. The effect on conjugate was greater, but ammonium chloride also affected cell growth in general. Leupeptin, an inhibitor of both serine and cysteine cathepsins, reduced conjugate cytotoxicity to one fortieth of the uninhibited level with no effect on free methotrexate. E64, a specific inhibitor of cysteine cathepsins, had a similar but smaller effect. Pepstatin A and chymostatin, specific inhibitors of aspartic and serine cathepsins respectively, had no significant effect on the cytotoxicity of the conjugate. These results indicate a lysosomal mechanism of action mediated by cysteine cathepsins, although the contribution of other enzymes cannot be ruled out by these experiments. Bestatin, Poly I:C, PPD and a pyrimidinone (2-amino-3-bromo-6-phenyl-4-pyrimidinone, ABPP, Milas et al. (1983) Clin. Exp. Met., 1, 213) have been tested for therapeutic effectiveness against the metastasising rat mammary carcinoma Sp4.
Bestatin (5mgkg-1 i.p. twice weekly) restricted development of post-surgical lymph node metastases and poly I:C: (1 mgkg-1 i.p.) These studies have failed to detect anti-tumour effects of ABPP against the rat mammary carcinoma Sp4, although this tumour is suppressed by Bestatin, poly I:C and PPD. In addition the indication is that ABPP might have some suppressive effect on delayed hypersensitivity reactions. In order to assess whether exposure to stress was associated with an increased risk of breast cancer, 100 women presenting with carcinoma of the breast completed a standard life events inventory documenting life stresses experienced during the previous three years. The same questionnaire was completed by 100 women presenting with benign breast lumps and 100 healthy controls. Both groups of patients with breast disease also completed the Eysenck personality inventory. There was no difference in the number of stressful life events experienced by the patients with benign and malignant breast lesions and the nature and severity of those stresses encountered were similar for both groups. The personality indices were also the same for both groups. The controls, however, recorded singnificantly higher levels of stress exposure than the patients with breast disease. On the basis of these results there is no evidence to support the hypothesis that stress predisposes to breast cancer development or presentation. (Ho (1977) Arch. Virol., 5, 1). Adjuvant chemotherapy is also known to have immunosuppressive effects. The aim of this study was to determine the incidence of viral infection in patients receiving cytotoxic chemotherapy following mastectomy for breast cancer.
One hundred and twenty-four patients attending a breast clinic were studied. Sixty-four patients were currently receiving cytotoxic chemotherapy (CMF), the remaining patients acting as controls. Blood samples were taken at 3 monthly intervals and standard screens for antibodies to respiratory viruses performed. A 4-fold increase in antibody titre between two consecutive samples was considered evidence of recent infection.
Patients receiving CMF had 123 infections during 444 (1 per 3.6) patient months of study. In controls 63 infections occurred during 495 (1 per 7.8) patient months (P < 0.05). The common viruses encountered were herpes simplex (26%), influenza A (17%) and para influenza (13%). Less common viruses encountered in the CMF patients included RSV (13%), CMV (8%), M. pneumoniae (6%).
These results show that patients receiving cytotoxic chemotherapy are at high risk of viral infection and such infections may add to morbidity during treatment. (LFTs) was seen in 92%, affecting ALT ( < 3 x normal in 50% of patients, >3x normal in 33%) but also AP (75% and 0%) and Gamma GT (58% and 17%). This was associated with malaise, which occurred 3-10 days after treatment, in 46% of patients. Prednisolone cover relieved malaise in all cases. LFTs spontaneously improved in 4 of 7 patients given more than 2 courses. Other toxicities included nausea/vomiting (19%) and conjunctivitis (12.5%); myelotoxicity was not seen (median nadir Hb. 9.9gdl-1, WBC 6.4, platelets 247x 1091-1. These preliminary results confirm that CB3717 is active in advanced breast cancer, with minimal myelosuppression but significant renal and symptomatic hepatic toxicity. Responses are brief in these heavily pre-treated patients; the drug may be more effective as first-line chemotherapy. Table   Staging   To-I   T2   T3 T4
BS (-) 20 (77) 57 (86) 85 (72) (a) tissue localisation through capillary blockade of particular organs with particles of requisite size and (b) control of drug release from carrier. In order to examine the latter point a system was developed that involved immobilising drug-containing microspheres on a glass wool column subjected to aqueous buffer at a constant flow rate, and analysis of the eluate for adriamycin (Adx).
Time taken for elution of 50% of Adx (T,0), measured by total fluorescence and high pressure liquid chromatography, was compared with regard to (a) protein (albumin, haemoglobin) used as the microsphere matrix, (b) concentration of crosslinking agent (glutaraldehyde) used in microsphere formation and (c) microsphere size. It was found that for Adx-loaded microspheres prepared using 1% glutaraldehyde, albumin (T = 3.5h) gave more protracted drug elution than haemoglobin or free drug (T50 = 2.6h and 2.2h). Moreover, for albumin microspheres, increasing glutaraldehyde concentration and particle size both decreased elution rates, although the maximum T,0 was still only 5 h.
Total drug content was measured after digestion of microspheres with trypsin and in this case total fluorescence measurements were a reliable measure of Adx content only under certain conditions; namely, using albumin as matrix protein and < I% glutaraldehyde. Under such conditions it was observed that not all drug was released in vitro.
These data are consistent with in vivo results showing an initial, relatively rapid release of a proportion of drug from intact microspheres, with the remainder only becoming available when the structural integrity of the particles is compromised. Photodynamic therapy (systemic administration of tumour-localising porphyrin followed by exposure of the tumour to light) may be a useful treatment for malignant brain tumours as (i) porphyrins are excluded from most of the brain by the blood-brain barrier (BBB) but not from tumours, (ii) the brain is relatively translucent to light of the appropriate wave-lengths, (iii) brain tumours rarely metastasize and so, in principle, the whole tumour can be illuminated, (iv) the results of other treatments are poor.
However, we find that injection of HPD in rodents produces a long-lasting (>3 months) photosensitization of normal brain, exposure of the cranium to light causing a rapid and usually fatal cerebral oedema. Surviving animals show necrosis of illuminated areas of brain. The possibilities are either (i) HPD, contrary to current belief, does pass the BBB or (ii) HPD is retained for a remarkably long time on the vascular side of the BBB. Our evidence suggests the latter, viz (i) the oedema is of vasogenic origin, (ii) the brain is immediately sensitized by an injection of protein-bound HPD, (iii) conventional histology shows early endothelial cell necrosis, (iv) electron microscopy shows opening of endothelial tight junctions. These findings may be relevant to the mechanisms by which photodynamic therapy damages tumours.
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